IP Library Granted Patent US 12708695
Granted Patent B2
US 12708695 · App. 18/612,434 · Granted Aug 18, 2026

Soft tissue adhesive composition of alpha-TCP and phosphorylated amino acid

Inventors: Philip Procter (Divonne les Bains, FR); Håkan Engqvist (Uppsala, SE); Michael Pujari-Palmer (Uppsala, SE); Gerard Insley (Limerick, IE)
Assignee: BIOMIMETIC INNOVATIONS LIMITED
A61L24/0031A61L24/0084A61L24/02A61L27/54A61L2430/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12708695
App. No.
18/612,434
Filed
Mar 21, 2024
Granted
Aug 18, 2026
Kind
B2
Art Unit
1615
USPC
424/400
Abstract

The present invention relates to a soft tissue adhesive comprising an aqueous composition comprising α-TCP and a phosphorylated amino acid. The composition has improved mechanical strength and is easily applied to the tissue.

Claims (16)

1 . A method of adhering a first soft tissue to a second soft tissue using a tissue adhesive comprising an aqueous solution, α-TCP, and a phosphorylated amino acid, wherein the tissue adhesive does not comprise a silicate compound, wherein the method comprises:

a. applying the tissue adhesive to the first soft tissue or to the second soft tissue and optionally leave it for a suitable period of time;

b. bringing the first tissue and the second tissue into contact with each other;

c. optionally applying a pressure on the first and second tissue for a suitable period of time; and

d. letting the tissue adhesive cure;

wherein the amount of phosphorylated amino acid is 40-90 wt % of the solid content.

2 . The method according to claim 1 wherein the steps are performed in vitro.

3 . The method according to claim 1 wherein the amount of the phosphorylated amino acid is 60-80 wt %.

4 . The method according to claim 1 wherein at least 95 wt % of the tissue adhesive comprises the aqueous solution, α-TCP and the phosphorylated amino acid.

5 . The method according to claim 1 wherein at least 98 wt % of the tissue adhesive comprises the aqueous solution, α-TCP and the phosphorylated amino acid.

6 . The method according to claim 1 wherein at least 98 wt % of the tissue adhesive comprises the aqueous solution, α-TCP and wherein the amount of phosphorylated amino acid is 60-80 wt %.

7 . The method according to claim 1 wherein the phosphorylated amino acid is phosphorylated serine.

8 . The method according to claim 1 wherein the aqueous solution is water.

9 . The method according to claim 1 wherein the tissue adhesive further comprises a hydrogel.

10 . The method according to claim 1 wherein the tissue adhesive further comprises collagen.

11 . The method according to claim 1 wherein at least one of the first and the second soft tissue is selected from tendon, ligament, fascia, skin, fibrous tissue, muscle, fat, nerve or blood vessel.